Chemical Compound

2-[[(2S)-2-benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]propanoyl]amino]acetic acid<br/>ADL 8-2698<br/>ADL8-2698<br/>alvimopan<br/>alvimopan anhydrous<br/>anhydrous alvimopan<br/>Entereg<br/>LY 246736<br/>LY-246736<br/>LY246736<br/>trans-3,4-dimethyl-4-(3-hydroxyphenyl) pipe

CAS Registry Number 156053-89-3
2-[[(2S)-2-benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]propanoyl]amino]acetic acid<br/>ADL 8-2698<br/>ADL8-2698<br/>alvimopan<br/>alvimopan anhydrous<br/>anhydrous alvimopan<br/>Entereg<br/>LY 246736<br/>LY-246736<br/>LY246736<br/>trans-3,4-dimethyl-4-(3-hydroxyphenyl) pipe 结构式
Primary record

2-[[(2S)-2-benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]propanoyl]amino]acetic acid<br/>ADL 8-2698<br/>ADL8-2698<br/>alvimopan<br/>alvimopan anhydrous<br/>anhydrous alvimopan<br/>Entereg<br/>LY 246736<br/>LY-246736<br/>LY246736<br/>trans-3,4-dimethyl-4-(3-hydroxyphenyl) pipe

库存
1,914 克
纯度
99.5 %
CAS
156053-89-3

化合物标识与属性

CAS
156053-89-3
PubChem CID
5488548
SMILES
C[C@H]1CN(CC[C@@]1(C)C2=CC(=CC=C2)O)C[C@H](CC3=CC=CC=C3)C(=O)NCC(=O)O
Canonical SMILES
C[C@H]1CN(C[C@H](Cc2ccccc2)C(=O)NCC(=O)O)CC[C@@]1(C)c1cccc(O)c1

名称与同义词

  • Alvimopan
  • Entereg
  • Alvimopan anhydrous
  • 156053-89-3
  • anhydrous alvimopan
  • alvimopanum
  • Alvimopan dihydrate
  • Alvimopan [INN]
  • Adl 8-2698
  • Entereg (TN)
  • -Methylenecycloketones
  • LY-246736 dihydrate
  • ALVIMOPAN [MI]
  • UNII-Q153V49P3Z
  • AC1NUQN6
  • RefChem:111766
  • LY246736
  • ALVIMOPAN [MART.]
  • D0D7KC
  • ALVIMOPAN [WHO-DD]
  • Q153V49P3Z
  • MFCD09838268
  • SCHEMBL49578
  • DTXSID60166035
  • C25H32N2O4
  • CHEMBL270190
  • GTPL7471
  • LY 246736
  • orb1309266
  • Alvimopan, >=98% (HPLC)
  • DTXCID7088526
  • CTK8F0805
  • HSDB 7704
  • A06AH02
  • LY-246736
  • ADL8-2698
  • CHEBI:135686
  • 677C126AET
  • GLXC-08199
  • HMS3886B09
  • ADL-8-2698
  • ANHYDROUS ALVIMOPAN [MART.]
  • ZINC3802417
  • BDBM50088381
  • EBC-27050
  • s5935
  • trans-3,4-dimethyl-4-(3-hydroxyphenyl) piperidine
  • AKOS015896476
  • C25-H32-N2-O4
  • 2-((S)-2-benzyl-3-((3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl)propanamido)acetic acid
  • ACN-047960
  • CID5488548
  • CS-0536
  • DB06274
  • FA17336
  • RTX-013338
  • CID:5488548
  • NCGC00378640-01
  • NCGC00378640-02
  • NCGC00378640-03
  • AJ-45653
  • AS-35088
  • HY-13243
  • S036
  • SID:134224030
  • J605.686E
  • LY-246376
  • NS00069226
  • ST24039017
  • ST24045942
  • ADL 8-2698;LY 246736
  • Glycine, N-[(2S)-2-[[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl]-1-oxo-3-phenylpropyl]-
  • A11292
  • A11881
  • SBI-0654641.0001
  • W-5416
  • 145590-44-9
  • 2-[[(2S)-2-benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]propanoyl]amino]acetic acid
  • EN300-7393122
  • 053A893
  • A882054
  • C419502
  • SR-01000945029
  • I06-1921
  • Q4738021
  • SR-01000945029-1
  • BRD-K07857022-002-01-1
  • 170098-38-1
  • 2-[(2S)-2-benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]propanamido]acetic acid
  • N-[(2S)-2-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]methyl}-3-phenylpropanoyl]glycine
  • ((S)-2-benzyl-3-((3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl)propanoyl)glycine
  • Glycine, N-((2S)-2-(((3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl)methyl)-1-oxo-3-phenylpropyl)-
  • (((2S)-2-(((3R,4R)-4-(3-HYDROXYPHENYL)-3,4-DIMETHYLPIPERIDIN-1-YL)METHYL)-3-PHENYLPROPANOYL)AMINO)ACETIC ACID
  • (((2S)-2-(((3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl)methyl)-3-phenylpropanoyl)amino)acetic acid dihydrate
  • ((2(S)-((4(R)-(3-HYDROXYPHENYL)-3(R),4-DIMETHYL-1-PIPERIDINYL)METHYL)-1-OXO-3-PHENYLPROPYL)AMINO)ACETIC ACID
  • [[(S)-2-Benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]propionyl]amino]acetic acid
  • 110-129-5
  • 2-(((2S)-2-(((3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl)methyl)-3-phenylpropanoyl)amino)acetic acid
  • 2-((2S)-2-benzyl-3-((3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl)propanamido)acetic acid
  • 2-((S)-2-benzyl-3-((3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl)propanamido)aceticacid
  • 2-[[(2S)-2-[[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]methyl]-3-phenylpropanoyl]amino]acetic acid
  • 2-[[(2S)-2-benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidyl]propanoyl]amino]acetic acid
  • 2-[[(2S)-2-benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]propanoyl]amino]acetic acid<br/>ADL 8-2698<br/>ADL8-2698<br/>alvimopan<br/>alvimopan anhydrous<br/>anhydrous alvimopan<br/>Entereg<br/>LY 246736<br/>LY-246736<br/>LY246736<br/>trans-3,4-dimethyl-4-(3-hydroxyphenyl) pipe
  • GLYCINE, N-(2-((4-(3-HYDROXYPHENYL)-3,4-DIMETHYL-1-PIPERIDINYL)METHYL)-1-OXO-3-PHENYLPROPYL)-, (3R-((S*),3.ALPHA.,4.ALPHA.))-
  • Glycine, N-[(2S)-2-[[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl]-1-oxo-3-phenylpropyl]-; Glycine, N-[2-[[4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl]-1-oxo-3-phenylpropyl]-, [3R-[1(S*),3a,4a]]-; ADL 8-2698; Alvimopan; Entereg; LY 246736
  • Glycine, N-[2-[[4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl]-1-oxo-3-phenylpropyl
  • N-((2S)-2-(((3R,4R)-4-(3-HYDROXYPHENYL)-3,4-DIMETHYL-1-PIPERIDINYL)METHYL)-1-OXO-3-PHENYLPROPYL)GLYCINE
  • N-[(2S)-2-[[(3R,4R)-4-(3-Hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl]-1-oxo-3-phenylpropyl]glycine
  • NG0